Search icon

ENDOCRINE TECHNOLOGY, LLC

Company Details

Name: ENDOCRINE TECHNOLOGY, LLC
Jurisdiction: New York
Legal type: DOMESTIC LIMITED LIABILITY COMPANY
Status: Active
Date of registration: 12 Feb 2002 (23 years ago)
Entity Number: 2730588
ZIP code: 11217
County: New York
Place of Formation: New York
Address: 304 LIVINGSTON STREET, BROOKLYN, NY, United States, 11217

DOS Process Agent

Name Role Address
THE LLC DOS Process Agent 304 LIVINGSTON STREET, BROOKLYN, NY, United States, 11217

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

CAGE Code:
5XSY3
UEI Expiration Date:
2020-02-06

Business Information

Division Name:
CLINICAL
Activation Date:
2019-02-07
Initial Registration Date:
2010-03-21

National Provider Identifier

NPI Number:
1275992034

Authorized Person:

Name:
DR. KUMARPAL AMBALAL SHAH
Role:
PRESIDENT
Phone:

Taxonomy:

Selected Taxonomy:
261QH0100X - Health Service Clinic/Center
Is Primary:
No
Selected Taxonomy:
207RE0101X - Endocrinology, Diabetes & Metabolism Physician
Is Primary:
Yes

Contacts:

Fax:
7182221350

Filings

Filing Number Date Filed Type Effective Date
061102000082 2006-11-02 CERTIFICATE OF PUBLICATION 2006-11-02
060131002498 2006-01-31 BIENNIAL STATEMENT 2006-02-01
020212000711 2002-02-12 ARTICLES OF ORGANIZATION 2002-02-12

Trademarks Section

Serial Number:
78100190
Mark:
ETBOND TECHNOLOGY
Status:
REGISTERED AND RENEWED
Mark Type:
TRADEMARK
Application Filing Date:
2001-12-28
Mark Drawing Type:
Typeset: Word(s)/letter(s)/number(s)
Mark Literal Elements:
ETBOND TECHNOLOGY

Goods And Services

For:
Pharmaceutical preparations for the treatment of hyperkalemia, which lowers serum potassium levels, and stimulates the immune system
First Use:
2003-03-15
International Classes:
005 - Primary Class
Class Status:
Active

Date of last update: 30 Mar 2025

Sources: New York Secretary of State